Aloflute 25 microgram/125 microgram per metered dose pressurised inhalation, suspension. Each metered dose (ex valve) contains: 25 micrograms of salmeterol (as salmeterol xinafoate) and 125 micrograms of fluticasone propionate.

ALOFLUTE 25 MICROGRAM/125 MICROGRAM PER METERED DOSE PRESSURISED INHALATION SUSPENSION. Active substance(s): FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE. PDF options: View Fullscreen Download PDF

Aloflute 25 Mikrogramm/125 Mikrogramm pro Sprühstoß Druckgasinhalation, Suspension

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aloflute 25 microgram/125 microgram per metered dose pressurised inhalation, suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each metered dose (ex valve) contains: 25 micrograms of salmeterol (as salmeterol xinafoate) and 125 micrograms of fluticasone propionate.

Fluticasone propionate is a corticosteroid which reduces swelling and irritation in the lungs. Aloflute is indicated for use in adults 18 years of age and older only. Aloflute is NOT indicated for use in children 12 years of age and younger or adolescents 13 to 17 years of age.

Aloflute 25micrograms / dose / 125micrograms / dose inhaler (Mylan) 120 dose Type Pressurised aerosol inhaler (MDI) Medicine Fluticasone 125micrograms/dose + Salmeterol 25micrograms/dose

Long-acting selective beta2 agonist with corticosteroid. Adult: 2 inhalations twice daily. For the prophylaxis of asthma, and the management of adult patients with moderate to severe asthma and COPD. Pressurised inhalation. More on: Bronchodilators , Compound preparations.

2022年10月13日 · - Two inhalations of 25 micrograms salmeterol and 125 micrograms fluticasone propionate twice daily. A short term trial of salmeterol/fluticasone propionate may be considered as initial maintenance therapy in adults with moderate persistent asthma (defined as patients with daily symptoms, daily rescue use and moderate to severe airflow ...

Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.

Aloflute is indicated for use in adults 18 years of age and older only. Aloflute is NOT indicated for use in children 12 years of age and younger or adolescents 13 to 17 years of age. The doctor has prescribed this medicine to help prevent breathing problems such as asthma. You must use Aloflute every day as directed by your doctor.